Nouvelle déclaration d'incident
No de la demande: 2020-2303
Numéro de référence du titulaire d'homologation: 2020-CA-000002
Nom du titulaire (nom légal complet, aucune abbréviation): The Hartz Mountain Corporation
Adresse: 400 Plaza Drive
Ville: Secaucus
État: New Jersey
Pays: USA
Code postal /Zip: 07094-3688
Incident chez un animal domestique
Pays: CANADA
État: UNKNOWN
ARLA No d'homologation 29930 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Hartz UltraGuard OneSpot Flea and Tick Cat Drops
Oui
Inconnu
Site: Animal / Usage sur un animal domestique
Propriétaire de l'animal
Cat / Chat
Domestic Shorthair
1
Femme
0.7
6
lbs
Cutanée
>1 wk <=1 mo / > 1 sem < = 1 mois
>24 hrs <=3 days / >24 h <=3 jours
Système
Unknown / Inconnu
Non
Non
Unknown/Inconnu
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On 29-Dec-2019, an 8 month old, approximately 6 pound, intact, female, Domestic Shorthair cat, in unknown condition, with no known concomitant medical conditions, was administered 1 tube of Hartz UltraGuard OneSpot Flea and Tick Cat Drops (S-Methoprene) via the topical route by the animal owner. On 01-Jan-2020, the cat developed application site pruritus, application site erythema, application site alopecia, and application site bleeding. An unknown amount of unspecified antibiotic cream, was applied to the affected area, via the topical route by the animal owner. On approximately 03-Jan-2020, the cat developed a scab at the application site. On 06-Jan-2020, the cat continued to scratch at the application site, causing the scab to break open, resulting in bleeding.The cat was not evaluated by a veterinarian, no treatment was performed and the signs persisted at the time of the call. Veterinary evaluation was recommended. No further information was received in this case.
Mineure
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.